Thiazolidinediones: the case for early use.
Kendall
David M
DM
Chief of Clinical Services and Medical Director, International Diabetes Center, 3800 Park Nicollet Blvd., Minneapolis, Minnesota 55416-2699, USA. david.kendall@parknicollet.com
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D012449:Safety; D045162:Thiazolidinediones / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones